Article
In silico identification and verification of Tanshinone IIA-related prognostic genes in hepatocellular carcinoma
31 Oct 2024
Abstract excerpt
Background Currently, adequate treatment and prognostic prediction means for Hepatocellular Carcinoma (HCC) haven’t entered into medical vision. Tanshinone IIA (TanIIA) is a natural product, which can be utilized as a potential treatment of HCC due to its high anti-tumor activity. However, the effect on HCC prognosis, as well as the potential targets and molecular mechanism of TanIIA still remain ambiguous....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
